Invitae slumps 23% on 2023 guidance, debt agreement
Lemon_tm
- Invitae Corp. (NYSE:NVTA) is off 23% in Wednesday afternoon trading after issuing lackluster guidance and signing exchange and financing agreements with Deerfield Management Company.
- The medical genetics company said it expects 2023 revenue of "over $500M," which represents low double-digit year-over-year growth. Consensus is $518.33M.
- Invitae (NVTA) added it sees non-GAAP gross margin of 48%-50%, compared to 42.5% in 2022. Also, cash burn is expected to be $250M-275M, more than 45% less than in 2022.
- The company intends to exchange about $306M 2% convertible senior notes due 2024 (old notes) for about $275M of new 4.5% series A convertible senior secured notes due 2028.
- In its Q4 2022 quarterly results released Tuesday, Invitae (NVTA) beat on the top and bottom lines.